Your browser doesn't support javascript.
loading
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial.
Aghajanian, Carol; Swisher, Elizabeth M; Okamoto, Aikou; Steffensen, Karina Dahl; Bookman, Michael A; Fleming, Gini F; Friedlander, Michael; Moore, Kathleen N; Tewari, Krishnansu S; O'Malley, David M; Chan, John K; Ratajczak, Christine; Hashiba, Hideyuki; Wu, Meijing; Dinh, Minh H; Coleman, Robert L.
Afiliação
  • Aghajanian C; Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: aghajanc@MSKCC.ORG.
  • Swisher EM; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
  • Okamoto A; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
  • Steffensen KD; Department of Oncology, Lillebaelt University Hospital of Southern Denmark, Vejle, Denmark.
  • Bookman MA; Kaiser Permanente Northern California, San Francisco, CA, USA.
  • Fleming GF; The University of Chicago Medicine, Chicago, IL, USA.
  • Friedlander M; Prince of Wales Clinical School UNSW, Prince of Wales Hospital and ANZGOG, Sydney, Australia.
  • Moore KN; Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Tewari KS; University of California, Irvine Medical Center, Orange, CA, USA.
  • O'Malley DM; The Ohio State University Comprehensive Cancer Center - James, Columbus, OH, USA.
  • Chan JK; Palo Alto Medical Foundation, California Pacific Medical Center, Sutter Health, San Francisco, CA, USA.
  • Ratajczak C; AbbVie Inc., North Chicago, IL, USA.
  • Hashiba H; AbbVie GK, Tokyo, Japan.
  • Wu M; AbbVie Inc., North Chicago, IL, USA.
  • Dinh MH; AbbVie Inc., North Chicago, IL, USA.
  • Coleman RL; US Oncology Research, The Woodlands, TX, USA.
Gynecol Oncol ; 164(2): 278-287, 2022 02.
Article em En | MEDLINE | ID: mdl-34930617
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Benzimidazóis / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Neoplasias Císticas, Mucinosas e Serosas / Síndrome Hereditária de Câncer de Mama e Ovário / Inibidores de Poli(ADP-Ribose) Polimerases / Carcinoma Epitelial do Ovário Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Benzimidazóis / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Neoplasias Císticas, Mucinosas e Serosas / Síndrome Hereditária de Câncer de Mama e Ovário / Inibidores de Poli(ADP-Ribose) Polimerases / Carcinoma Epitelial do Ovário Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article